CAPITOL COUNSEL LLC for ASTRAZENECA PHARMACEUTICALS, LP
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health care reform; drug safety and comparative effectiveness; follow-on biologics, including related provisions in HR 3200 and S. 1679, America's Affordable Health Choices Act and the Senate Finance Committee's America's Healthy Future Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE FINLEY | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| DREW GOESL New | Communications Dir., Sen. Blanche Lincoln |
| JAMES GOULD | — |
| DENISE HENRY MORRISEY | — |
| DAVID JONES | — |
| JOHN D RAFFAELLI | — |
| RICHARD LYLES SULLIVAN | — |
Medicare/Medicaid MMM
Medicare and Medicaid coverage, coding and reimbursement of pharmaceuticals and Medicare coverage gap, including related provisions in HR 3200, America's Affordable Health Choices Act and the Senate Finance Committee's America's Healthy Future Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE FINLEY | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| DREW GOESL New | Communications Dir., Sen. Blanche Lincoln |
| JAMES GOULD | — |
| DENISE HENRY MORRISEY | — |
| DAVID JONES | — |
| JOHN D RAFFAELLI | — |
| RICHARD LYLES SULLIVAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.